Literature DB >> 23279800

Reliable diagnosis of post-kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures.

Sandeep Verma1, Vasundhra Bhandari, Kumar Avishek, Venkatesh Ramesh, Poonam Salotra.   

Abstract

OBJECTIVE: Confirmatory diagnosis of post-kala-azar dermal leishmaniasis (PKDL) is primarily based on invasive skin biopsy procedure. We evaluated the utility of minimally invasive slit aspirate specimen for serological and molecular diagnosis of PKDL. We compared the PKDL diagnosis using slit aspirate and skin biopsy specimens from the same patients.
METHODS: Serological diagnosis using rK39 strip test was performed with serum and slit aspirate sample; molecular diagnosis for parasite detection and quantification was carried out by quantitative real-time PCR (Q-PCR) with skin biopsy and slit aspirate sample.
RESULTS: The rK39 serological strip test was positive in all PKDL cases with both slit aspirate and serum samples (n = 50) and negative in all control cases (n = 24), giving a sensitivity of 100% (95% CI: 92.9-100%) and a specificity of 100% (95% CI: 86.2-100%). Quantitative-PCR detected parasite in all PKDL slit aspirates (n = 50, sensitivity = 100%, 95% CI: 92.9-100%) and tissue biopsies (n = 46, sensitivity = 100%, 95% CI: 92.3-100; it was negative in all controls including dermal tissues (n = 24) and slit aspirates (n = 24), giving specificity of 100% (95% CI: 86.2-100%). The parasite load in tissue and slit aspirate samples was significantly (P < 0.0001) correlated (r = 0.82).
CONCLUSIONS: Slit aspirates are a simpler and minimally invasive sampling technique for initial screening by serology followed by confirmatory diagnosis of PKDL with microscopy and/or Q-PCR. The simplified procedure has the potential for epidemiological studies and assessment of cure in PKDL.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23279800     DOI: 10.1111/tmi.12047

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  19 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.

Authors:  Krishna Pandey; Biplab Pal; Niyamat Ali Siddiqui; Chandra Shekhar Lal; Vahab Ali; Sanjiva Bimal; Ashish Kumar; Neena Verma; Vidya Nand Rabi Das; Shubhankar Kumar Singh; Roshan Kamal Topno; Pradeep Das
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

3.  [Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?]

Authors:  Soumiya Chiheb; Zineb Tazi Saoud; Imane El Idrissi Saik; Dounia Darif; Fouzia Hali; Fatima Zahra El Fatoiki; Hayat Skali Dahbi; Ayyoub Kihel; Ikram Hammi; Maha Soussi Abdellaoui; Myriam Riyad
Journal:  Med Trop Sante Int       Date:  2021-11-05

4.  Development of a novel loop-mediated isothermal amplification assay for rapid detection of Mycobacterium leprae in clinical samples.

Authors:  Shweta Joshi; Vanila Sharma; V Ramesh; Ruchi Singh; Poonam Salotra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-03-02       Impact factor: 2.545

5.  Leishmaniases diagnosis: an update on the use of immunological and molecular tools.

Authors:  Milena de Paiva-Cavalcanti; Rayana Carla Silva de Morais; Rômulo Pessoa-E-Silva; Lays Adrianne Mendonça Trajano-Silva; Suênia da Cunha Gonçalves-de-Albuquerque; Diego de Hollanda Cavalcanti Tavares; Maria Carolina Accioly Brelaz-de-Castro; Rafael de Freitas E Silva; Valéria Rêgo Alves Pereira
Journal:  Cell Biosci       Date:  2015-06-17       Impact factor: 7.133

6.  Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection.

Authors:  Sandeep Verma; Ruchi Singh; Vanila Sharma; Ram Avtar Bumb; Narendra Singh Negi; V Ramesh; Poonam Salotra
Journal:  BMC Infect Dis       Date:  2017-03-23       Impact factor: 3.090

7.  Development of a novel loop-mediated isothermal amplification assay for rapid detection of Mycobacterium leprae in clinical samples.

Authors:  Shweta Joshi; Vanila Sharma; V Ramesh; Ruchi Singh; Poonam Salotra
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

8.  Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.

Authors:  Keerti Kaumudee Dixit; V Ramesh; Shreya Upadhyay; Abhishek Kumar Singh; Om Prakash Singh; Shyam Sundar; Ruchi Singh; Poonam Salotra
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

9.  Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.

Authors:  V Ramesh; Ruchi Singh; Kumar Avishek; Aditya Verma; Deepak Kumar Deep; Sandeep Verma; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2015-10-22

10.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.